drugset / Trial / NCT02101476
An Open Label, Prospective Study of the Analgesic Efficacy of Oral Xartemis Compared to Generic Oxycodone/APAP( Acetaminophen) in the Treatment of Moderate to Severe Post Operative Pain.
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the analgesic efficacy of Xartemis 15mg/650mg by mouth every 12 hours for the management of acute moderate to severe post operative pain to generic Oxycodone/APAP(acetaminophen) (Percocet) 10mg/650mg by mouth every 6 hours.
Timeline
- Start
- 2014-05
- Primary completion
- 2014-08
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acetaminophen | Small molecule | 650 mg | Oral |
| Comparator | Oxycodone | Other / unclassified | 10 mg | Oral |
| Comparator | Xartemis | Unknown | 15 mg | Oral |
| Comparator | Xartemis | Unknown | 650 mg | Oral |
Indications
No indication recorded.